ThermoGenesis Holdings, Inc. develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market.
Company profile
Ticker
THMO
Exchange
Website
CEO
Xiaochun Xu
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CESCA THERAPEUTICS INC., THERM0GENESIS CORP, THERMOGENESIS CORP
SEC CIK
Corporate docs
Subsidiaries
ThermoGenesis Corp. • Wholly-owned by ThermoGenesis Holdings, Inc. • CARTXpress Bio Inc. ...
IRS number
943018487
THMO stock data
Latest filings (excl ownership)
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update
15 May 23
EFFECT
Notice of effectiveness
2 May 23
CORRESP
Correspondence with SEC
27 Apr 23
UPLOAD
Letter from SEC
25 Apr 23
S-3
Shelf registration
18 Apr 23
424B3
Prospectus supplement
17 Apr 23
EFFECT
Notice of effectiveness
17 Apr 23
S-3/A
Shelf registration (amended)
13 Apr 23
CORRESP
Correspondence with SEC
11 Apr 23
Transcripts
THMO
Earnings call transcript
2023 Q1
15 May 23
THMO
Earnings call transcript
2022 Q4
30 Mar 23
THMO
Earnings call transcript
2022 Q3
12 Nov 22
THMO
Earnings call transcript
2022 Q2
13 Aug 22
THMO
Earnings call transcript
2022 Q1
19 May 22
THMO
Earnings call transcript
2021 Q4
28 Mar 22
THMO
Earnings call transcript
2021 Q3
13 Nov 21
THMO
Earnings call transcript
2021 Q2
13 Aug 21
THMO
Earnings call transcript
2021 Q1
13 May 21
THMO
Earnings call transcript
2020 Q4
18 Mar 21
Latest ownership filings
SC 13D/A
Boyalife Group, Inc.
11 Apr 23
SC 13D/A
Xu Xiaochun
9 Mar 23
SC 13D/A
FOLEY & LARDNER/ FA
16 Feb 23
SC 13D/A
Boyalife Group, Inc.
9 Nov 22
SC 13D/A
Boyalife Asset Holding II, Inc.
5 Aug 22
SC 13D/A
Boyalife Asset Holding II, Inc.
12 Jul 22
4
Xiaochun Xu
30 Jun 22
3
VIVIAN H LIU
27 Jun 22
3
Haihong Zhu
27 Jan 22
4
Xiaochun Xu
1 Jun 21
Financial summary
| Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 5.85 mm | 5.85 mm | 5.85 mm | 5.85 mm | 5.85 mm | 5.85 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 348.33 k | 502.42 k | 205.00 k | 311.58 k |
| Cash used (since last report) | n/a | n/a | 759.34 k | 1.10 mm | 446.88 k | 679.23 k |
| Cash remaining | n/a | n/a | 5.09 mm | 4.76 mm | 5.41 mm | 5.17 mm |
| Runway (months of cash) | n/a | n/a | 14.6 | 9.5 | 26.4 | 16.6 |
Institutional ownership, Q4 2022
| 13F holders | Current |
|---|---|
| Total holders | 11 |
| Opened positions | 1 |
| Closed positions | 9 |
| Increased positions | 0 |
| Reduced positions | 9 |
| 13F shares | Current |
|---|---|
| Total value | 31.01 mm |
| Total shares | 120.80 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Boyalife | 70.98 mm | $7.16 mm |
| Boyalife Asset Holding II | 49.80 mm | $10.57 mm |
| Millennium Management | 14.74 k | $47.00 k |
| MS Morgan Stanley | 2.64 k | $8.44 mm |
| BLK Blackrock | 1.49 k | $4.77 mm |
| Tower Research Capital | 891.00 | $3.00 k |
| RY Royal Bank Of Canada | 20.00 | $0.00 |
| Advisor | 14.00 | $0.00 |
| WFC Wells Fargo & Co. | 5.00 | $16.00 k |
| BAC Bank Of America | 2.00 | $6.00 k |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 28 Jun 22 | Xu Xiaochun | Common Stock | Conversion | Acquire C | Yes | No | 0.2843 | 10,552,234 | 3.00 mm | 12,281,091 |
| 28 Jun 22 | Xu Xiaochun | Second Amended and Restated Convertible Note Common Stock | Conversion | Dispose C | Yes | No | 0.2843 | - | 3.00 mm | - |
News
Stocks That Hit 52-Week Lows On Wednesday
24 May 23
Stocks That Hit 52-Week Lows On Monday
22 May 23
Stocks That Hit 52-Week Lows On Tuesday
16 May 23
HC Wainwright & Co. Reiterates Buy on ThermoGenesis Holdings, Maintains $5 Price Target
16 May 23
ThermoGenesis Holdings Q1 Adj EPS $(3.88) Misses $(0.31) Estimate, Sales $2.57M Miss $2.80M Estimate
15 May 23
Press releases
ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update
15 May 23
ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update
10 May 23
ThermoGenesis Holdings Announces Year End 2022 Financial Results and Provides Corporate Update
30 Mar 23
ThermoGenesis Holdings to Announce Financial Results for the Year Ended December 31, 2022 and Provide a Corporate Strategic Update
28 Mar 23
THERMOGENESIS CLOSES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES
20 Mar 23